Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers.

Weijers JM, Semb AG, Rollefstad S, Kitas GD, van Riel PLCM; ATrans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA).

Rheumatol Int. 2020 Apr;40(4):523-527. doi: 10.1007/s00296-020-04533-4. Epub 2020 Feb 22.

PMID:
32088752
2.

How do people with rheumatoid arthritis experience participation in a smoking cessation trial: a qualitative study.

Roelsgaard IK, Thomsen T, Østergaard M, Semb AG, Andersen L, Esbensen BA.

Int J Qual Stud Health Well-being. 2020 Dec;15(1):1725997. doi: 10.1080/17482631.2020.1725997.

3.

Effects of long-term statin-treatment on coronary atherosclerosis in patients with inflammatory joint diseases.

Svanteson M, Rollefstad S, Kløw NE, Hisdal J, Ikdahl E, Sexton J, Haig Y, Semb AG.

PLoS One. 2019 Dec 12;14(12):e0226479. doi: 10.1371/journal.pone.0226479. eCollection 2019.

4.

Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients.

Roelsgaard IK, Ikdahl E, Rollefstad S, Wibetoe G, Esbensen BA, Kitas GD, van Riel P, Gabriel S, Kvien TK, Douglas K, Wållberg-Jonsson S, Rantapää Dahlqvist S, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon CA, Pascual-Ramos V, Contreras-Yáñez I, Sfikakis PP, González-Gay MA, Crowson CS, Semb AG.

Rheumatology (Oxford). 2019 Nov 28. pii: kez557. doi: 10.1093/rheumatology/kez557. [Epub ahead of print]

PMID:
31782789
5.

Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A.

Eur Heart J. 2019 Sep 21;40(36):3010-3012. doi: 10.1093/eurheartj/ehz650. No abstract available.

PMID:
31541549
6.

Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases.

Roelsgaard IK, Esbensen BA, Østergaard M, Rollefstad S, Semb AG, Christensen R, Thomsen T.

Cochrane Database Syst Rev. 2019 Sep 2;9:CD012958. doi: 10.1002/14651858.CD012958.pub2.

PMID:
31476270
7.

Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al.

Agca R, Heslinga SC, Rollefstad S, Heslinga S, Södergren A, Semb AG, Kitas GD, Sattar N, Nurmohamed MT; EULAR task force “EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update”.

Ann Rheum Dis. 2019 Aug 14. pii: annrheumdis-2019-215748. doi: 10.1136/annrheumdis-2019-215748. [Epub ahead of print] No abstract available.

PMID:
31413003
8.

Biomarkers of cardiovascular risk across phenotypes of osteoarthritis.

Provan SA, Rollefstad S, Ikdahl E, Mathiessen A, Berg IJ, Eeg I, Wilkinson IB, McEniery CM, Kvien TK, Hammer HB, Østerås N, Haugen IK, Semb AG.

BMC Rheumatol. 2019 Aug 8;3:33. doi: 10.1186/s41927-019-0081-8. eCollection 2019.

9.

Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.

Savarese G, Reiner MF, Uijl A, D'Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS.

Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):86-93. doi: 10.1093/ehjcvp/pvz036.

PMID:
31392312
10.

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A.

Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):171-180. doi: 10.1093/ehjcvp/pvz016.

PMID:
31119266
11.

High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients.

Sveaas SH, Bilberg A, Berg IJ, Provan SA, Rollefstad S, Semb AG, Hagen KB, Johansen MW, Pedersen E, Dagfinrud H.

Br J Sports Med. 2020 Mar;54(5):292-297. doi: 10.1136/bjsports-2018-099943. Epub 2019 Feb 11.

PMID:
30745314
12.

Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project.

Ikdahl E, Rollefstad S, Wibetoe G, Salberg A, Krøll F, Bergsmark K, Kvien TK, Olsen IC, Soldal DM, Bakland G, Lexberg Å, Gjesdal CG, Gulseth C, Haugeberg G, Semb AG.

RMD Open. 2018 Oct 1;4(2):e000737. doi: 10.1136/rmdopen-2018-000737. eCollection 2018.

13.

Left Ventricular Systolic Myocardial Function in Ankylosing Spondylitis.

Midtbø H, Semb AG, Matre K, Rollefstad S, Berg IJ, Gerdts E.

Arthritis Care Res (Hoboken). 2019 Sep;71(9):1276-1283. doi: 10.1002/acr.23765. Epub 2019 Aug 7.

PMID:
30242984
14.

The effect of brief versus individually tailored dietary advice on change in diet, lipids and blood pressure in patients with inflammatory joint disease.

Fagerhøi MG, Rollefstad S, Olsen SU, Semb AG.

Food Nutr Res. 2018 Sep 4;62. doi: 10.29219/fnr.v62.1512. eCollection 2018.

15.

Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases.

Ikdahl E, Wibetoe G, Rollefstad S, Salberg A, Bergsmark K, Kvien TK, Olsen IC, Soldal DM, Bakland G, Lexberg Å, Fevang BTS, Gulseth HC, Haugeberg G, Semb AG.

Int J Cardiol. 2019 Jan 1;274:311-318. doi: 10.1016/j.ijcard.2018.06.111. Epub 2018 Jul 2.

PMID:
30007486
16.

Associations Between Cardiorespiratory Fitness and Arterial Stiffness in Ankylosing Spondylitis: A Cross-sectional Study.

Berg IJ, Semb AG, Sveaas SH, Fongen C, van der Heijde D, Kvien TK, Dagfinrud H, Provan SA.

J Rheumatol. 2018 Nov;45(11):1522-1525. doi: 10.3899/jrheum.170726. Epub 2018 Jul 1.

PMID:
29961684
17.

Ankylosing Spondylitis Is Associated with Increased Prevalence of Left Ventricular Hypertrophy.

Midtbø H, Gerdts E, Berg IJ, Rollefstad S, Jonsson R, Semb AG.

J Rheumatol. 2018 Aug;45(9):1249-1255. doi: 10.3899/jrheum.171124. Epub 2018 Jun 1.

PMID:
29858235
18.

Optimization of CVD prevention in psoriatic arthritis.

Semb AG, Rollefstad S.

Nat Rev Rheumatol. 2018 Jun;14(6):323-324. doi: 10.1038/s41584-018-0002-z. No abstract available.

PMID:
29686327
19.

Change in cardiovascular risk factors in patients who develop psoriatic arthritis: longitudinal data from the Nord-Trøndelag Health Study (HUNT).

Gulati AM, Salvesen Ø, Thomsen RS, Kavanaugh A, Semb AG, Rollefstad S, Haugeberg G, Hoff M.

RMD Open. 2018 Mar 14;4(1):e000630. doi: 10.1136/rmdopen-2017-000630. eCollection 2018.

20.

Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases.

Wibetoe G, Ikdahl E, Rollefstad S, Olsen IC, Bergsmark K, Kvien TK, Salberg A, Soldal DM, Bakland G, Lexberg Å, Fevang BT, Gulseth HC, Haugeberg G, Semb AG.

Int J Cardiol. 2018 Feb 1;252:201-206. doi: 10.1016/j.ijcard.2017.10.038.

PMID:
29249429
21.

The effect of an intensive smoking cessation intervention on disease activity in patients with rheumatoid arthritis: study protocol for a randomised controlled trial.

Roelsgaard IK, Thomsen T, Østergaard M, Christensen R, Hetland ML, Jacobsen S, Andersen L, Tønnesen H, Rollefstad S, Semb AG, Esbensen BA.

Trials. 2017 Nov 28;18(1):570. doi: 10.1186/s13063-017-2309-5.

22.

Associations between coronary and carotid artery atherosclerosis in patients with inflammatory joint diseases.

Svanteson M, Rollefstad S, Kløw NE, Hisdal J, Ikdahl E, Semb AG, Haig Y.

RMD Open. 2017 Sep 17;3(2):e000544. doi: 10.1136/rmdopen-2017-000544. eCollection 2017.

23.

Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3.

Gulati AM, Hoff M, Salvesen Ø, Dhainaut A, Semb AG, Kavanaugh A, Haugeberg G.

RMD Open. 2017 Jul 13;3(1):e000413. doi: 10.1136/rmdopen-2016-000413. eCollection 2017.

24.

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Crowson CS, Rollefstad S, Ikdahl E, Kitas GD, van Riel PLCM, Gabriel SE, Matteson EL, Kvien TK, Douglas K, Sandoo A, Arts E, Wållberg-Jonsson S, Innala L, Karpouzas G, Dessein PH, Tsang L, El-Gabalawy H, Hitchon C, Ramos VP, Yáñez IC, Sfikakis PP, Zampeli E, Gonzalez-Gay MA, Corrales A, Laar MV, Vonkeman HE, Meek I, Semb AG; A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA).

Ann Rheum Dis. 2018 Jan;77(1):48-54. doi: 10.1136/annrheumdis-2017-211735. Epub 2017 Sep 6.

25.

Cardiovascular disease risk profiles in inflammatory joint disease entities.

Wibetoe G, Ikdahl E, Rollefstad S, Olsen IC, Bergsmark K, Kvien TK, Salberg A, Soldal DM, Bakland G, Lexberg Å, Fevang BT, Gulseth HC, Haugeberg G, Semb AG.

Arthritis Res Ther. 2017 Jul 3;19(1):153. doi: 10.1186/s13075-017-1358-1.

26.

Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.

Crowson CS, Rollefstad S, Kitas GD, van Riel PL, Gabriel SE, Semb AG; A Trans-Atlantic Cardiovascular Risk Consortium for Rheumatoid Arthritis (ATACC-RA).

PLoS One. 2017 Apr 7;12(4):e0175605. doi: 10.1371/journal.pone.0175605. eCollection 2017.

27.

Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.

Crowson CS, Gabriel SE, Semb AG, van Riel PLCM, Karpouzas G, Dessein PH, Hitchon C, Pascual-Ramos V, Kitas GD; Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis.

Rheumatology (Oxford). 2017 Jul 1;56(7):1102-1110. doi: 10.1093/rheumatology/kex038.

28.

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.

Crowson CS, Rollefstad S, Kitas GD, van Riel PL, Gabriel SE, Semb AG; A Trans-Atlantic Cardiovascular Risk Consortium for Rheumatoid Arthritis (ATACC-RA).

PLoS One. 2017 Mar 23;12(3):e0174656. doi: 10.1371/journal.pone.0174656. eCollection 2017. Erratum in: PLoS One. 2017 Apr 7;12 (4):e0175605.

29.

Response to: 'Disease activity and left ventricular systolic function in rheumatoid arthritis' by Giollo et al.

Midtbø H, Semb AG, Matre K, Kvien TK, Gerdts E.

Ann Rheum Dis. 2016 Dec;75(12):e84. doi: 10.1136/annrheumdis-2016-210516. Epub 2016 Oct 14. No abstract available.

PMID:
27742659
30.

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT.

Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3. Review.

PMID:
27697765
31.

Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases.

Semb AG, Ikdahl E, Hisdal J, Olsen IC, Rollefstad S.

Int J Cardiol. 2016 Nov 15;223:331-336. doi: 10.1016/j.ijcard.2016.08.129. Epub 2016 Aug 7.

PMID:
27543704
32.

Spondyloarthropathies: CVD prevention and statin therapy in ankylosing spondylitis.

Semb AG, Rollefstad S.

Nat Rev Rheumatol. 2016 Aug;12(8):441-2. doi: 10.1038/nrrheum.2016.103. Epub 2016 Jun 30. No abstract available.

PMID:
27357255
33.

Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis.

Ikdahl E, Rollefstad S, Wibetoe G, Olsen IC, Berg IJ, Hisdal J, Uhlig T, Haugeberg G, Kvien TK, Provan SA, Semb AG.

J Rheumatol. 2016 Sep;43(9):1622-30. doi: 10.3899/jrheum.160053. Epub 2016 Jun 15.

PMID:
27307523
34.

Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis.

Midtbø H, Semb AG, Matre K, Kvien TK, Gerdts E.

Ann Rheum Dis. 2017 Feb;76(2):371-376. doi: 10.1136/annrheumdis-2016-209223. Epub 2016 Jun 7.

PMID:
27269296
35.

The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis.

Midtbø H, Gerdts E, Kvien TK, Olsen IC, Lønnebakken MT, Davidsen ES, Rollefstad S, Semb AG.

Blood Press. 2016 Oct;25(5):298-304. doi: 10.3109/08037051.2016.1172867. Epub 2016 Apr 28.

PMID:
27123584
36.

Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study.

Ikdahl E, Rollefstad S, Hisdal J, Olsen IC, Pedersen TR, Kvien TK, Semb AG.

PLoS One. 2016 Apr 19;11(4):e0153440. doi: 10.1371/journal.pone.0153440. eCollection 2016.

37.

Chronic kidney disease reduces risk of cardiovascular disease in patients with rheumatoid arthritis according to the QRISK lifetime cardiovascular risk calculator.

Ikdahl E, Rollefstad S, Wibetoe G, Semb AG.

Rheumatology (Oxford). 2016 Aug;55(8):1528-9. doi: 10.1093/rheumatology/kew002. Epub 2016 Feb 8. No abstract available.

PMID:
26857077
38.

Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases.

Rollefstad S, Ikdahl E, Hisdal J, Kvien TK, Pedersen TR, Semb AG.

Front Med (Lausanne). 2015 Nov 10;2:80. doi: 10.3389/fmed.2015.00080. eCollection 2015.

39.

Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study.

Ikdahl E, Hisdal J, Rollefstad S, Olsen IC, Kvien TK, Pedersen TR, Semb AG.

Arthritis Res Ther. 2015 Oct 8;17:279. doi: 10.1186/s13075-015-0795-y.

40.

The Impact of Newer Biological Disease Modifying Anti-Rheumatic Drugs on Cardiovascular Risk Factors: A 12-Month Longitudinal Study in Rheumatoid Arthritis Patients Treated with Rituximab, Abatacept and Tociliziumab.

Provan SA, Berg IJ, Hammer HB, Mathiessen A, Kvien TK, Semb AG.

PLoS One. 2015 Jun 26;10(6):e0130709. doi: 10.1371/journal.pone.0130709. eCollection 2015.

41.

Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management.

Dessein PH, Semb AG, González-Gay MA, Popa CD.

Biomed Res Int. 2015;2015:850671. doi: 10.1155/2015/850671. Epub 2015 Mar 12. No abstract available.

42.

EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: an audit of the success of implementation in a rheumatology outpatient clinic.

Ikdahl E, Rollefstad S, Olsen IC, Kvien TK, Hansen IJ, Soldal DM, Haugeberg G, Semb AG.

Biomed Res Int. 2015;2015:515280. doi: 10.1155/2015/515280. Epub 2015 Mar 1.

43.

On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study.

Gulati AM, Semb AG, Rollefstad S, Romundstad PR, Kavanaugh A, Gulati S, Haugeberg G, Hoff M.

Ann Rheum Dis. 2016 May;75(5):819-24. doi: 10.1136/annrheumdis-2014-206824. Epub 2015 Mar 26.

PMID:
25814652
44.

CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up.

Berg IJ, Semb AG, van der Heijde D, Kvien TK, Olsen IC, Dagfinrud H, Provan SA.

Ann Rheum Dis. 2015 Aug;74(8):1562-6. doi: 10.1136/annrheumdis-2014-206773. Epub 2015 Mar 20.

PMID:
25795906
45.

Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.

Rollefstad S, Ikdahl E, Hisdal J, Olsen IC, Holme I, Hammer HB, Smerud KT, Kitas GD, Pedersen TR, Kvien TK, Semb AG.

Arthritis Rheumatol. 2015 Jul;67(7):1718-28. doi: 10.1002/art.39114.

46.

Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study.

Sveaas SH, Berg IJ, Provan SA, Semb AG, Olsen IC, Ueland T, Aukrust P, Vøllestad N, Hagen KB, Kvien TK, Dagfinrud H.

Scand J Rheumatol. 2015;44(2):118-24. doi: 10.3109/03009742.2014.956142.

PMID:
25756521
47.

Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.

Arts EE, Popa CD, Den Broeder AA, Donders R, Sandoo A, Toms T, Rollefstad S, Ikdahl E, Semb AG, Kitas GD, Van Riel PL, Fransen J.

Ann Rheum Dis. 2016 Apr;75(4):674-80. doi: 10.1136/annrheumdis-2014-206879. Epub 2015 Feb 17.

PMID:
25691119
48.

Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study.

Berg IJ, van der Heijde D, Dagfinrud H, Seljeflot I, Olsen IC, Kvien TK, Semb AG, Provan SA.

J Rheumatol. 2015 Apr;42(4):645-53. doi: 10.3899/jrheum.141018. Epub 2015 Feb 1.

PMID:
25641897
49.

ESC guidelines adherence is associated with improved survival in patients from the Norwegian Heart Failure Registry.

De Blois J, Fagerland MW, Grundtvig M, Semb AG, Gullestad L, Westheim A, Hole T, Atar D, Agewall S.

Eur Heart J Cardiovasc Pharmacother. 2015 Jan;1(1):31-6. doi: 10.1093/ehjcvp/pvu010.

PMID:
27533962
50.

Serum samples that have been stored long-term (>10 years) can be used as a suitable data source for developing cardiovascular risk prediction models in large observational rheumatoid arthritis cohorts.

Arts EE, Popa CD, Smith JP, Arntz OJ, van de Loo FA, Donders R, Semb AG, Kitas GD, van Riel PL, Fransen J.

Biomed Res Int. 2014;2014:930925. doi: 10.1155/2014/930925. Epub 2014 Sep 11.

Supplemental Content

Support Center